Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€4.58

€4.58

-1.130%
-0.052
-1.130%
-
 
17.10.25 / Tradegate WKN: A2P71U / Name: Curevac / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Curevac

sharewise wants to provide you with the best news and tools for Curevac, so we directly link to the best financial data sources.

News

CureVac Stock: BioNTech's Billion-Dollar Takeover Bid
CureVac Stock: BioNTech's Billion-Dollar Takeover Bid

The biotech landscape was shaken Thursday as BioNTech announced a takeover offer for Tübingen-based CureVac, valuing the company at approximately $1.25 billion (€1.08 billion). Under the proposed

EQS-News: CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates
EQS-News: CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates
EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech
EQS-News: CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech
EQS-News: CureVac Announces Voting Results of General Meeting: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Announces Voting Results of General Meeting
EQS-News: CureVac Announces Voting Results of General Meeting
EQS-News: CureVac Announces Financial Results for the First Quarter of 2025 and Provides  Business Updates: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
EQS-News: CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
EQS-News: CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE: https://upload.wikimedia.org/wikipedia/de/thumb/2/27/Curevac_logo.svg/500px-Curevac_logo.svg.png
EQS-News: CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE
EQS-News: CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE